The Effect Of Education Given According to Meleıs' Transitional Theory to Patients With Pacemaker
NCT ID: NCT06204601
Last Updated: 2024-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2022-11-10
2023-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Secondary Prevention Education After Acute Myocardial Infarction
NCT04769219
The Effect of Education on Environmental Stressors Perceived by Patients
NCT06174974
Clinical, Psychosocial, and Comfort Effects of Hybrid Education in Hemodialysis Patients: A Randomized Controlled Trial
NCT07095491
Myocardial Infarction
NCT06948123
The Effect of Education Given Before Port Catheter Infusion on Infusion Related Symptoms
NCT07002190
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypotheses of the Research H01: Training given to patients with pacemaker implantation according to Meleis's Transition Theory does not affect the anxiety and depression levels of the patients.
H11: Training given according to Meleis's Transition Theory to patients with pacemaker implants reduces the anxiety and depression levels of patients.
H02: Training given to patients with pacemaker implantation according to Meleis's Transition Theory does not affect the self-efficacy level of the patients.
H12: Training given to patients with pacemakers according to Meleis's Transition Theory increases the self-efficacy level of the patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
Experimental group
Education According to Meleis' Transitional Theory to Patients With Pacemaker
Patients in the experimental group will be trained according to Meleis's Transition Theory.
Control group
Control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education According to Meleis' Transitional Theory to Patients With Pacemaker
Patients in the experimental group will be trained according to Meleis's Transition Theory.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages 18 and over,
* The one who is literate,
* Open to communication and collaboration,
* Patients who volunteer to participate in the study will be included in the study.
Exclusion Criteria
* Hearing loss,
* Cannot understand and speak Turkish and
* Patients who do not want to continue the study will be excluded from the study.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ordu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hacer Gok Ugur
Associate Professor.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hacer GÖK UĞUR, Asos.Prof.
Role: PRINCIPAL_INVESTIGATOR
Ordu Univercity
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacer GOK UGUR
Ordu, Altınordu, Turkey (Türkiye)
Hacer GÖK UĞUR
Ordu, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2Ordu
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.